Why IRADIMED CORP (NASDAQ:IRMD) should be investigated by quality investors.

Quality investors are looking for the best of the best. Companies which are growing steadily and consistently, but are also in excellent financial condition. We will have a look here to see if IRADIMED CORP (NASDAQ:IRMD) is suited for quality investing. Investors should of course do their own research, but we spotted IRADIMED CORP showing up in our Caviar Cruise quality screen, so it may be worth spending some more time on it.

Some of the quality metrics of IRMD highlighted

• IRMD has shown strong performance in revenue growth over the past 5 years, with a 13.71% increase. This indicates the company's ability to generate consistent revenue growth and reflects its potential for long-term success.
• IRMD demonstrates impressive performance in terms of ROIC excluding cash and goodwill, with a 50.43% ratio. This highlights the company's efficient utilization of capital and its focus on maximizing returns for investors.
• With a Debt/Free Cash Flow Ratio of 0.0, IRMD exhibits solid financial health and responsible debt management practices. This ratio indicates the company's ability to generate ample free cash flow to meet its debt obligations and pursue growth opportunities.
• The Profit Quality (5-year) of IRMD stands at 135.0%, highlighting its ability to consistently generate reliable profits. This metric underscores the company's strong business fundamentals and reinforces its position as a financially stable entity.
• IRMD has consistently achieved strong EBIT growth over the past 5 years, with a 20.49% increase. This underscores the company's effective management of its operating income and suggests a positive outlook for future profitability.
• IRMD demonstrates a remarkable trend where its EBIT 5-year growth exceeds its Revenue 5-year growth. This indicates the company's ability to enhance its profitability through improved cost control and operational efficiency.

How does the complete fundamental picture look for IRMD?

ChartMill utilizes a proprietary algorithm to assign a Fundamental Rating to every stock. This rating, ranging from 0 to 10, is computed daily by analyzing a variety of fundamental indicators and properties.

We assign a fundamental rating of 7 out of 10 to IRMD. IRMD was compared to 189 industry peers in the Health Care Equipment & Supplies industry. IRMD scores excellent points on both the profitability and health parts. This is a solid base for a good stock. IRMD has a correct valuation and a medium growth rate. These ratings would make IRMD suitable for quality investing!

Our latest full fundamental report of IRMD contains the most current fundamental analsysis.

More ideas for quality investing can be found on ChartMill in our Caviar Cruise screen.

Disclaimer

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.